Listen to this article

India Bans 35 Fixed-Dose Combination Drugs Including Painkillers; Glenmark Recalls 24 U.S. Medicines, $422M ADHD Drug Launch Set

13 posts • GPT (4.1 mini)

Updated Apr 18, 2025, 06:12 PM

The Indian government has banned the manufacture and sale of 35 fixed-dose combination (FDC) drugs, including painkillers, anti-diabetics, and nutrition supplements, following safety concerns and complaints about adverse health effects. These drugs were reportedly being sold without proper safety evaluations. Concurrently, Glenmark Pharmaceuticals, an Indian drug manufacturer, has recalled 24 generic medicines in the United States due to non-compliance with U.S. manufacturing standards at one of its factories.

The recalled drugs cover a range of treatments, including epilepsy, diabetes, multiple sclerosis, heart disease, and high blood pressure. Glenmark's U.S. arm is also set to distribute a $422 million drug for ADHD treatment starting in May. Additionally, blood pressure medications have been recalled in multiple countries, including Canada, due to labeling and dosing errors. The recalls and bans highlight ongoing regulatory scrutiny over drug safety and manufacturing quality standards globally.

More breaking stories on DeepNewz — updated live.

#Indian #Glenmark Pharmaceuticals #United States #Glenmark #Canada

Related Prediction Markets

•

View market suggestions→

Sources

propublica.org(3)economictimes.indiatimes.com(2)dailymail.co.uk ctvnews.ca

Daily Mail Online

@MailOnline

Forty lifesaving drugs taken by millions are recalled over fears of 'adverse health consequences' https://t.co/cFFQhfaveC

CTV News

@CTVNews

Two medications recalled in Canada due to dosing errors https://t.co/hfxtR7JExQ

ProPublica

@propublica

The Glenmark drug recalls cover a wide range of commonly prescribed medicines — including ones that treat epilepsy, diabetes, multiple sclerosis, heart disease and high blood pressure. https://t.co/Qb3mgu8P6a

Story Timeline

2 months ago•Latest version

India Bans 35 Fixed-Dose Combination Drugs Including Painkillers; Glenmark Recalls 24 U.S. Medicines, $422M ADHD Drug Launch Set

2 months ago•Original version

Glenmark Recalls 24 U.S. Drugs Over Indian Factory Issues, Linked to Patient Deaths; $422 Million ADHD Drug Launch Planned

India Bans 35 Fixed-Dose Combination Drugs Including Painkillers; Glenmark Recalls 24 U.S. Medicines, $422M ADHD Drug Launch Set

Related Prediction Markets

Sources

Story Timeline

Similar Stories